A tragic but avoidable outbreak is unfolding in Pennsylvania, where a newborn is one of two people who have died from measles in Lancaster County. Both victims were unvaccinated, and the deaths underscore how quickly measles can exploit gaps in immunization coverage — a threat that is now spreading, with Maryland officially declaring outbreaks in three counties. These are not isolated events; they are the predictable consequence of eroding vaccination protections that once kept such diseases at bay. On a more hopeful front, medicine is delivering breakthroughs that could fundamentally change how we manage chronic disease. The FDA has approved Eli Lilly’s Mounjaro to lower the risk of heart attacks and other cardiac events in people with diabetes, expanding the drug’s role beyond blood sugar control. Even more striking, researchers reported promising results from an experimental one-time CRISPR treatment for high cholesterol. If it holds up, this gene-editing therapy could free millions from a lifetime of daily statins. Heart disease remains the world’s leading killer, so lowering LDL cholesterol with a single shot would be a genuine paradigm shift. Meanwhile, public health messaging faces a crisis of credibility. A Slate analysis notes that while overall drinking rates are at a 92-year low, alcohol consumption among pregnant women is rising — and the author argues that fear-based campaigns may be backfiring. At the same time, a growing number of women are opting for “free births” at home without any medical attendant, a trend that worries obstetricians for obvious safety reasons. And the American Academy of Pediatrics is having to explicitly distance itself from anti-trans activists who cite the group’s name to justify demanding genital exams of school athletes. Between measles outbreaks, rising vaccine refusal, and a distrust of institutional guidance, the system is being tested from many angles at once. Also worth noting: the University of Arizona landed a $30 million grant to study whether blood transfusions administered by ground EMS crews can improve trauma survival — a practical study with enormous potential to save lives in the field.